Last Price
40.26
Today's Change
+0.605 (1.52%)
Day's Change
39.40 - 43.24
Trading Volume
181,805
Overview
Market Cap
523 Million
Shares Outstanding
12 Million
Avg Volume
172,992
Avg Price (50 Days)
47.01
Avg Price (200 Days)
39.04
PE Ratio
-10.97
EPS
-3.67
Earnings Announcement
14-Nov-2024
Previous Close
39.66
Open
39.50
Day's Range
39.4 - 43.24
Year Range
12.49 - 74.49
Trading Volume
181,807
Price Change Highlight
1 Day Change
1.53%
5 Day Change
-42.30%
1 Month Change
-19.07%
3 Month Change
19.94%
6 Month Change
27.62%
Ytd Change
102.64%
1 Year Change
187.61%
3 Year Change
-67.89%
5 Year Change
-28.35%
10 Year Change
-72.12%
Max Change
-83.15%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
US Ordered TSMC to Halt Shipments of Chips for AI to China — Reuters
2
3
CEO Morning Brief
Dogecoin Outperforms Bitcoin as Trump Spurs Crypto Speculation
4
CEO Morning Brief
5
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
